Breaks Categories: News

TuesdayNov 03, 2020 1:02 pm

NetworkNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Call, Live Webcast to Discuss Q3 2020 Results, Clinical Pipeline

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, today announced that it will host a conference call and live webcast at 5:30 p.m. Eastern Time on Nov. 12, 2020. Topics will include review of the company’s third quarter 2020 results and an update on its clinical pipeline, including discussion of PCSA’s three clinical-stage drugs (each of which addresses potential billion-dollar markets). Interested parties may join the call by dialing 877-876-9176 (Toll Free) or 785-424-1670 (International) and access the live webcast via the following…

Continue Reading

TuesdayNov 03, 2020 12:26 pm

NetworkNewsBreaks – MUSA Auto Finance Partners with Two US Financial Institutions to Expand Car-Leasing Services

A PowerBand Solutions’ (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) partner, MUSA Auto Finance, has partnered with two large financial institutions and is adding dealers to its platform at a record pace as it expands its new- and used-car leasing platform. MUSA, an automotive finance and technology lender specializing in effortless leasing, is working with its new partners to achieve securitization. MUSA focuses on automating the time-consuming, manual processes typically involved with leasing and buying vehicles. For example, MUSA's technology platforms process applications, calculate leases, make auto-decisions regarding applications, provide approvals for dealer partners, and prefill lease contracts — all within…

Continue Reading

TuesdayNov 03, 2020 12:00 pm

NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Appoints Experienced Innovator as VP of Strategy

Brain Scientific (OTCQB: BRSF), a neurology-focused medical device and software company, has announced the appointment of a new vice president of strategy and business development. In her new role, Amy Griffith will be responsible for the company’s development of strategic and tactical initiatives, as well as new sales strategies. A veteran sales and innovation expert, Griffith has held executive management positions at leading technology companies and has also worked with start-ups, focusing on identifying and implementing strategic sales programs. With an expertise in the medical and health-care industry, Griffith has been deeply involved and brings impressive experience in strategic planning and…

Continue Reading

TuesdayNov 03, 2020 11:33 am

NetworkNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Achieves Major Milestone in US REE Production

Energy Fuels (NYSE American: UUUU) (TSX: EFR) today announced that the company has produced a rare earth element ("REE") carbonate concentrate ("REE Concentrate") on a pilot scale at its 100% owned White Mesa Mill (the “Mill”), located near Blanding, Utah. According to the update, the REE Concentrate was produced using the Mill’s existing infrastructure and technologies from a sample of monazite sands from a North American source. A valuable natural uranium ore, monazite sands also contain high concentrations of REEs. The Mill recovered high concentrations of REEs in the monazite sands in addition to the contained uranium, which will be…

Continue Reading

TuesdayNov 03, 2020 11:02 am

NetworkNewsBreaks – Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Schedules Release of Q1 2021 Financial Results, Conference Call

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a global diversified portfolio of distinct businesses, products and brands, today announced that it will be reporting its first quarter financial results for the three months ended September 30, 2020 after markets close on Monday, November 16, 2020. In addition, Supreme Cannabis will host a conference call to discuss the results at 8:00 a.m. Eastern Time on Tuesday, November 17, 2020. Interested parties may join the call by dialing 416-764-8659 or 1-888-664-6392 and entering conference ID number 67218125. The call may also be accessed through the following webcast link: https://nnw.fm/CHnAG. To…

Continue Reading

TuesdayNov 03, 2020 10:40 am

NetworkNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Filing Date for Second-Quarter Financial Report

Canopy Rivers (TSX: RIV) (OTC: CNPOF) has set a filing date for its Q2 2021 financial results. The company plans to release its Q2 FY 2021 financial report on Nov. 9, 2020, before the market opens. The company will host a live audio webcast to review the results, which cover financial numbers for the three and six months ended Sept. 30, 2020. Those interested can view the webcast here or call 1-888-390-0546 in North America (confirmation #58883266) to listen to the announcement. In addition, a replay of the entire webcast will be available until Nov. 16, 2020 by calling 1-888-390-0541 (entry code #883266).…

Continue Reading

TuesdayNov 03, 2020 10:04 am

NetworkNewsBreaks – Friendable Inc.’s (FDBL) Halloween Fan Pass Event Provides Virtual Stage for Artists

Friendable (OTC: FDBL) has announced that, through its exclusive Fan Pass app and website, it has wrapped another successful event. The recent Fan Pass Halloween streaming showcase featured four artists — S-mack (x2), Mamd, R.T.A and Ball Hog Beats —providing each one with a virtual stage specifically designed for their individual style and sound. The streaming showcase highlighted Fan Pass artists who had recently approved their Fan Pass artist channels and is an ideal example of how artists can schedule, promote and hold virtual events through the proprietary platform. The virtual venue lasted three hours and generated additional content for…

Continue Reading

MondayNov 02, 2020 3:11 pm

NetworkNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Advancing CBD Research to Bring Innovative Products to Underserved Markets

Jupiter Wellness (NASDAQ: JUPW) is a functional wellness and natural health products company. It leverages a proprietary line of offerings formulated to provide the therapeutic and medical benefits of cannabidiol (“CBD”). Jupiter Wellness is dedicated to advancing research into CBD for treatment and relief of a range of ailments, including ultraviolet exposure, psoriasis, eczema, skin aging and other conditions. Formed in 2018 and headquartered in Jupiter, Florida, Jupiter’s award-winning portfolio contains seven unique CBD brands targeting specific niches of the larger CBD space. Jupiter Wellness retails its full portfolio of brands and products on its ecommerce site at www.CBDCaring.com. For…

Continue Reading

MondayNov 02, 2020 12:29 pm

NetworkNewsBreaks – Organic Flower Investments Group Inc. (CSE: SOW) (OTC: QILFF) (FWB: 2K6) Announces Grant of Stock Options

Organic Flower (CSE: SOW) (OTC: QILFF) (FWB: 2K6) recently announced that, pursuant to the company’s stock option plan, it has granted incentive stock options to its directors, officers, employees and consultants. The options will allow the purchase of an aggregate of 5,000,000 common shares, with an exercise price of 0.19 per share, for up to five years. To view the full press release, visit https://nnw.fm/gHNkt About Organic Flower Investments Group Inc. Organic Flower specializes in investing into private and public companies engaged in a variety of industries, with a focus in the bio-medical, pharmaceutical and naturopathic sectors, which may include…

Continue Reading

MondayNov 02, 2020 12:10 pm

NetworkNewsBreaks – Oncocyte Corporation (NYSE American: OCX) Announces Q3 Growth of DetermaRx(TM) Physician Adoption, Testing Volume

Oncocyte (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, recently provided an update on DetermaRx’s global growth and adoption. According to the update, DetermaRx is a treatment stratification test that identifies stage I-IIA non-small cell lung cancer (“NSCLC”) patients at high risk of recurrence, despite ostensibly curative surgery, who may benefit from the addition of chemotherapy. Since its January commercial launch in the U.S., DetermaRx has begun to be reimbursed by Medicare and multiple private payers and has seen rapid adoption across 67 hospitals. “We…

Continue Reading